L-glutamine is also used to alleviate symptoms of sickle cell disease, but how this drug works has similarly been contentious ...

A University of Rochester hospital will open a patient study comparing the efficacy of SCD treatments to help families in ...

ST. LOUIS — All morning, nurses had been coming in, taking vitals, offering blankets, pressing buttons to silence alarms. It ...

Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreservation ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Sickle Cell Disease Market Size Was Valued at USD 2.40 Billion in 2023, and is Projected to Reach USD 12.38 Billion by 2032, ...

So that means the more African Americans who donate, the more chances people like Aimee, experiencing Sickle Cell have to ...

BEAM-101, a gene-editing stem cell therapy, showed early signs of efficacy among the first treated sickle cell patients in a ...

The 43-year-old had diagnoses of sickle cell disease, epilepsy and delusional disorder, and a jury found that he died of acute chest syndrome – the most common fatal complication of sickle cell ...

According to Uganda's Ministry of Health, around 250,000 people in the country live with sickle cell disease, including an estimated 20,000 to 25,000 babies ...

L-glutamine is also used to alleviate symptoms of sickle cell disease, but how this drug works has similarly been contentious ...

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of using decades-old transplant drugs alongside cutting-edge CRISPR medicines.